+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global RSV Diagnostics Market by Product (Instruments, Kits & Assays), Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), End-use - Forecast 2024-2030- Product Image
Global RSV Diagnostics Market by Product (Instruments, Kits & Assays), Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), End-use - Forecast 2024-2030- Product Image
Sale

Global RSV Diagnostics Market by Product (Instruments, Kits & Assays), Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), End-use - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889855
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The RSV Diagnostics Market size was estimated at USD 1.07 billion in 2023, USD 1.17 billion in 2024, and is expected to grow at a CAGR of 9.20% to reach USD 1.98 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the RSV Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the RSV Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the RSV Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altona Diagnostics GmbH, Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMérieux SA, BTNX Inc., CerTest Biotec S.L., CTK Biotech, Inc., Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, Meridian Bioscience, Inc., Pro-Lab Diagnostics Inc., Qiagen GmbH, Quidel Corporation, SA Scientific, Ltd., Sansure Biotech Inc., Sentinel Ch S.p.A., Serion GmbH, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Vela Diagnostics Holding Pte Ltd., Virax Biolabs Group Limited, and Weldon Biotech, Inc.

Market Segmentation & Coverage

This research report categorizes the RSV Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Instruments
    • Kits & Assays
  • Methods
    • Molecular Diagnostics
    • Rapid Antigen Detection Tests
  • End-use
    • Home Care
    • Hospital & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the RSV Diagnostics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the RSV Diagnostics Market?
  3. What are the technology trends and regulatory frameworks in the RSV Diagnostics Market?
  4. What is the market share of the leading vendors in the RSV Diagnostics Market?
  5. Which modes and strategic moves are suitable for entering the RSV Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. RSV Diagnostics Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of respiratory infections among population
5.1.1.2. Growing awareness about early diagnosis of infectious diseases
5.1.1.3. Increasing approvals for syncytial virus diagnostic product
5.1.2. Restraints
5.1.2.1. Product recall issues associated with RSV diagnostic products
5.1.3. Opportunities
5.1.3.1. Advancements in respiratory syncytial virus diagnosis
5.1.3.2. Growth in genomics and proteomics research
5.1.4. Challenges
5.1.4.1. Limitations associated with current RSV diagnostic products and procedures
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. RSV Diagnostics Market, by Product
6.1. Introduction
6.2. Instruments
6.3. Kits & Assays
7. RSV Diagnostics Market, by Methods
7.1. Introduction
7.2. Molecular Diagnostics
7.3. Rapid Antigen Detection Tests
8. RSV Diagnostics Market, by End-use
8.1. Introduction
8.2. Home Care
8.3. Hospital & Clinics
9. Americas RSV Diagnostics Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific RSV Diagnostics Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa RSV Diagnostics Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Altona Diagnostics GmbH
13.1.3. Atlas Medical GmbH
13.1.4. Becton, Dickinson and Company
13.1.5. Bio-Rad Laboratories, Inc.
13.1.6. bioMérieux SA
13.1.7. BTNX Inc.
13.1.8. CerTest Biotec S.L.
13.1.9. CTK Biotech, Inc.
13.1.10. Danaher Corporation
13.1.11. DiaSorin S.p.A.
13.1.12. F. Hoffmann-La Roche Ltd.
13.1.13. Hologic, Inc.
13.1.14. Merck KGaA
13.1.15. Meridian Bioscience, Inc.
13.1.16. Pro-Lab Diagnostics Inc.
13.1.17. Qiagen GmbH
13.1.18. Quidel Corporation
13.1.19. SA Scientific, Ltd.
13.1.20. Sansure Biotech Inc.
13.1.21. Sentinel Ch S.p.A.
13.1.22. Serion GmbH
13.1.23. Siemens Healthcare GmbH
13.1.24. Thermo Fisher Scientific Inc.
13.1.25. Vela Diagnostics Holding Pte Ltd.
13.1.26. Virax Biolabs Group Limited
13.1.27. Weldon Biotech, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. RSV DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. RSV DIAGNOSTICS MARKET SIZE, 2022 VS 2030
FIGURE 3. RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. RSV DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 8. RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2022 VS 2030 (%)
FIGURE 10. RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 12. RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. RSV DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RSV DIAGNOSTICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 9. RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RSV DIAGNOSTICS MARKET SIZE, BY RAPID ANTIGEN DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 12. RSV DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RSV DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 20. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 22. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 23. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 24. CANADA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 25. CANADA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 26. CANADA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 27. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 28. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 29. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 36. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 37. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 39. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 40. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 41. CHINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 42. CHINA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 43. CHINA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 44. INDIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. INDIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 46. INDIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 47. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 48. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 49. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 52. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 55. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 58. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 61. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 64. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 67. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 70. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 73. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 78. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 80. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 81. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 83. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 84. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 86. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 87. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 89. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 92. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 94. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 95. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. ITALY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. ITALY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 98. ITALY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 100. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 101. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 104. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 106. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 107. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. POLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. POLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 110. POLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. QATAR RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 112. QATAR RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 113. QATAR RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 116. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 122. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 124. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 125. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 128. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 130. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 131. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 134. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 136. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 137. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
TABLE 140. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 142. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 143. RSV DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Altona Diagnostics GmbH
  • Atlas Medical GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • BTNX Inc.
  • CerTest Biotec S.L.
  • CTK Biotech, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Pro-Lab Diagnostics Inc.
  • Qiagen GmbH
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Sansure Biotech Inc.
  • Sentinel Ch S.p.A.
  • Serion GmbH
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Vela Diagnostics Holding Pte Ltd.
  • Virax Biolabs Group Limited
  • Weldon Biotech, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages181
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.17 Billion
Forecasted Market Value ( USD ) by 2030 $ 1.98 Billion
Compound Annual Growth Rate9.2%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Respiratory Syncytial Virus Diagnostics Market Size, Share & Trends Analysis Report By Product (DFA, RADT, Molecular Diagnostics, Chromatographic Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Respiratory Syncytial Virus Diagnostics Market Size, Share & Trends Analysis Report By Product (DFA, RADT, Molecular Diagnostics, Chromatographic Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 118 Pages
  • Global
From
RSV Diagnostics - Global Strategic Business Report - Product Image

RSV Diagnostics - Global Strategic Business Report

  • Report
  • 233 Pages
  • Global
From
RSV Diagnostics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

RSV Diagnostics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Respiratory Syncytial Virus (RSV) Diagnostics Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Respiratory Syncytial Virus (RSV) Diagnostic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Respiratory Syncytial Virus (RSV) Diagnostic - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From

About the Respiratory Syncytial Virus Test Market

The Respiratory Syncytial Virus (RSV) Test is a type of infectious disease test used to detect the presence of the RSV virus in a patient's respiratory system. It is typically used to diagnose RSV infection in infants and young children, as well as in adults with weakened immune systems. The test is usually performed by collecting a sample of mucus from the nose or throat and then testing it for the presence of the virus. Results are usually available within a few days. The RSV Test market is a growing segment of the infectious disease testing industry, as the virus is highly contagious and can cause severe respiratory illness in infants and young children. The test is also used to monitor the effectiveness of treatments for RSV infection. Some companies in the RSV Test market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Quidel. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.